Grant: Idea to Innovation
Simon Fraser University
$14,963.00
Ultrasensitive Rapid Sensors Based on Asymmetric Two-Dimensional MoS2 Diodes for Detection of Biomarker Proteins of Alzheimer's disease
EF 2023-24
Résumé
Biomarkers are measurable indicators that help determine if a person may have or be at risk of developing a disease. Changes in the brain can start over a decade before first clinical symptoms are noticed in Alzheimer's disease (AD) patients. Screening of biomarker proteins in blood may help clinicians diagnose Alzheimer's disease at an early stage when treatments or life-style changes can be most effective.Existing biomarker protein detection methods are expensive and time consuming and do not scale for the average patient in most healthcare systems. SFU researchers have developed a new sensor to detect biomarker proteins. The core of the design implements an asymmetric geometry MoS2 diode-based biosensor for rapid, label-free, highly sensitive, and specific detection of tumor necrosis factor-a (TNF-a), a proinflammatory cytokine biomarker linked to AD. The current design is portable and produces a test result within minutes without the need for expensive equipment. This new diode sensor may be implemented in a point-of-care (POC) diagnostic device that is low cost and accessible at various medical centers where patients are examined on-site (e.g., a doctor's office, hospital, etc.). This provides for significantly enhanced accessibility when compared to current market solutions. Moreover, the readout from the diode sensor is instant and need not require an incubation period and/or sending off results to off-site for processing like other market solutions.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
581196-2023
Name nom
Adachi, Michael MM
Department département
Engineering Science, School of
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
14963
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2523
Research subject group en
Electrical and electronic engineering
Research subject group fr
Semiconductor fabrication and packaging
Research subject en
Génie électrique et électronique
Research subject fr
Fabrication et mise sous enveloppe de semi-conducteurs
Application title
Ultrasensitive Rapid Sensors Based on Asymmetric Two-Dimensional MoS2 Diodes for Detection of Biomarker Proteins of Alzheimer's disease
Keyword
2D materials; advanced manufacturing; Alzheimer's disease; biomarker proteins; dementia; device fabrication; diagnostic sensor; diode sensors; MoS2
Application summary
Biomarkers are measurable indicators that help determine if a person may have or be at risk of developing a disease. Changes in the brain can start over a decade before first clinical symptoms are noticed in Alzheimer's disease (AD) patients. Screening of biomarker proteins in blood may help clinicians diagnose Alzheimer's disease at an early stage when treatments or life-style changes can be most effective.Existing biomarker protein detection methods are expensive and time consuming and do not scale for the average patient in most healthcare systems. SFU researchers have developed a new sensor to detect biomarker proteins. The core of the design implements an asymmetric geometry MoS2 diode-based biosensor for rapid, label-free, highly sensitive, and specific detection of tumor necrosis factor-a (TNF-a), a proinflammatory cytokine biomarker linked to AD. The current design is portable and produces a test result within minutes without the need for expensive equipment. This new diode sensor may be implemented in a point-of-care (POC) diagnostic device that is low cost and accessible at various medical centers where patients are examined on-site (e.g., a doctor's office, hospital, etc.). This provides for significantly enhanced accessibility when compared to current market solutions. Moreover, the readout from the diode sensor is instant and need not require an incubation period and/or sending off results to off-site for processing like other market solutions.